Mifiact 25mg Tablet is a prescription-only medicine containing Mifepristone as the active ingredient. It is used to treat a range of endocrine disorders, including Cushing's syndrome, hyperaldosteronism, and breast cancer. Mifiact works by binding to the glucocorticoid receptor, thereby inhibiting the activity of cortisol and other glucocorticoids. This leads to a decrease in the production of cortisol and other glucocorticoids, resulting in a reduction of symptoms associated with Cushing's syndrome and hyperaldosteronism. In breast cancer, Mifiact has been shown to inhibit the growth of tumors and induce apoptosis. The recommended dose of Mifiact is 25mg once daily, and it should be taken for as long as prescribed by the attending physician. Mifiact may cause side effects such as nausea, vomiting, and headache, although these are typically mild and temporary. However, in rare cases, more severe reactions may occur, such as adrenal insufficiency, and patients should be closely monitored for these complications.